Canadian Centre on Substance Use and Addiction

Consultation on the Legislative Review of the Tobacco and Vaping Products Act

Submitted to Health Canada in April 2022.

Summarizes CCSA’s feedback on Health Canada’s consultation on the legislative review of the Tobacco and Vaping Products Act. Discusses the rise of vaping among young cannabis users and why it is important to maintain the existing list of prohibited ingredients and aromas in the act. The submission supports maintaining an evidence-based public health approach to cannabis regulation, including continued oversight to protect young people from the risks of vaping products.

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.